Scholarlink

<p>This study aimed to investigate the loss of cell viability and antioxidant effects of ketamine, propofol, and their combination, against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced oxidative stress in A549 cells. IC<sub>50</sub> values were determined by applying different concentrations of H<sub>2</sub>O<sub>2</sub> (100–2000 µM), propofol, ketamine, and a propofol-ketamine combination (10–2000&#xa0;µg/mL). Cell viability was assessed using the MTT assay after 24&#xa0;h. Based on the observed reduction in metabolic activity profiles, three specific concentrations (75, 125, 250&#xa0;µg/mL) were selected to evaluate the antioxidant responses. The protein levels of lysed cells were determined, and malondialdehyde (MDA), total antioxidant status (TAS), superoxide dismutase (SOD), and total glutathione (tGSH) were measured. Treatment with propofol, ketamine, and their combination was associated with lower levels of the lipid peroxidation marker MDA and with higher levels of antioxidant parameters (TAS, SOD, tGSH) under H<sub>2</sub>O<sub>2</sub>-induced oxidative stress, as compared with H<sub>2</sub>O<sub>2</sub>-only controls. The propofol-ketamine combination showed enhanced effects compared to individual treatments by further modulating antioxidant properties in A549 cells, warranting further investigation into their potential supportive roles in lung cancer models.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protective effects of propofol, ketamine, and their combination against H2O2-induced oxidative stress in A549 cells: an evaluation of metabolic activity and antioxidant defense

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月18日

查看全文
  • Zeyno Nuhoğlu,
  • Abdurrahman Aksoy

摘要

This study aimed to investigate the loss of cell viability and antioxidant effects of ketamine, propofol, and their combination, against hydrogen peroxide (H2O2)-induced oxidative stress in A549 cells. IC50 values were determined by applying different concentrations of H2O2 (100–2000 µM), propofol, ketamine, and a propofol-ketamine combination (10–2000 µg/mL). Cell viability was assessed using the MTT assay after 24 h. Based on the observed reduction in metabolic activity profiles, three specific concentrations (75, 125, 250 µg/mL) were selected to evaluate the antioxidant responses. The protein levels of lysed cells were determined, and malondialdehyde (MDA), total antioxidant status (TAS), superoxide dismutase (SOD), and total glutathione (tGSH) were measured. Treatment with propofol, ketamine, and their combination was associated with lower levels of the lipid peroxidation marker MDA and with higher levels of antioxidant parameters (TAS, SOD, tGSH) under H2O2-induced oxidative stress, as compared with H2O2-only controls. The propofol-ketamine combination showed enhanced effects compared to individual treatments by further modulating antioxidant properties in A549 cells, warranting further investigation into their potential supportive roles in lung cancer models.